Evidence map›Paper›PMID 27653841›Full record

ArticleNature communications2016

Sizing nanomaterials in bio-fluids by cFRAP enables protein aggregation measurements and diagnosis of bio-barrier permeability.

Ranhua Xiong, Roosmarijn E Vandenbroucke, Katleen Broos, Toon Brans, Elien Van Wonterghem, Claude Libert, Jo Demeester, Stefaan C De Smedt, Kevin Braeckmans

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ranhua XiongDepartment of Pharmaceutics, Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, Ghent 9000, Belgium.
Roosmarijn E VandenbrouckeInflammation Research Center, VIB, Ghent 9052, Belgium.ORCID http://orcid.org/0000-0002-8327-620X
Katleen BroosAnabiotec nv, Evergem 9940, Belgium.
Toon BransDepartment of Pharmaceutics, Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, Ghent 9000, Belgium.
Elien Van WonterghemInflammation Research Center, VIB, Ghent 9052, Belgium.
Claude LibertInflammation Research Center, VIB, Ghent 9052, Belgium.
Jo DemeesterDepartment of Pharmaceutics, Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, Ghent 9000, Belgium.
Stefaan C De SmedtDepartment of Pharmaceutics, Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, Ghent 9000, Belgium.
Kevin BraeckmansDepartment of Pharmaceutics, Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, Ghent 9000, Belgium.
Ghent University · BEBelgian Institute of Management Accountants & Controllers · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sizing nanomaterials in complex biological fluids, such as blood, remains a great challenge in spite of its importance for a wide range of biomedical applications. In drug delivery, for instance, it is essential that aggregation of protein-based drugs is avoided as it may alter their efficacy or elicit immune responses. Similarly it is of interest to determine which size of molecules can pass through biological barriers in vivo to diagnose pathologies, such as sepsis. Here, we report on continuous fluorescence recovery after photobleaching (cFRAP) as a analytical method enabling size distribution measurements of nanomaterials (1-100 nm) in undiluted biological fluids. We demonstrate that cFRAP allows to measure protein aggregation in human serum and to determine the permeability of intestinal and vascular barriers in vivo. cFRAP is a new analytical technique that paves the way towards exciting new applications that benefit from nanomaterial sizing in bio-fluids.

Identifiers

PMID27653841
PMCPMC5036146
OpenAlexW2521505833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.